By AdjAssocProf Clare Stirzaker

Preprints

Campbell E; Laven-Law G; Smith G; Peters T; Colino-Sanguino Y; Moulder D; Du Q; Jones A; Giles K; Khoury A; Stirzaker C; Hickey T; Mora FV; Clark S; Achinger-Kawecka J, 2024, Androgen stimulation rapidly reorganizes temporal 3D genome and epigenome states to trigger AR-mediated transcription in prostate cancer, http://dx.doi.org/10.1101/2024.12.17.628805

Johnston A; Antaw F; Lu J; Stirzaker C; Trau M; Korbie D, 2024, Unraveling cfDNA Fragmentation Patterns: Linking Chromatin Architecture to Cancer Diagnostic Sensitivity, http://dx.doi.org/10.1101/2024.11.16.623159

Achinger-Kawecka J; Stirzaker C; Portman N; Campbell E; Chia K-M; Du Q; Laven-Law G; Nair S; Yong A; Wilkinson A; Clifton S; Milioli H; Alexandrou S; Caldon E; Song J; Khoury A; Meyer B; Gee JMW; Schmitt A; Wong E; Hickey T; Lim E; Clark S, 2021, Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer, http://dx.doi.org/10.1101/2021.06.21.449340

Luu P-L; Ong P-T; Loc TTH; Lam D; Pidsley R; Stirzaker C; Clark SJ, 2020, MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection, http://dx.doi.org/10.1101/2020.02.09.941013

Lam D; Clark S; Stirzaker C; Pidsley R, 2020, Advances in Prognostic Methylation Biomarkers for Prostate Cancer, http://dx.doi.org/10.20944/preprints202010.0154.v1

Du Q; Bert S; Armstrong N; Caldon E; Song J; Nair S; Gould C; Luu PL; Khoury A; Qu W; Zotenko E; Stirzaker C; Clark S, 2018, Replication timing shapes the cancer epigenome and the nature of chromosomal rearrangements, http://dx.doi.org/10.1101/251280

Riebler A; Menigatti M; Song JZ; Statham AL; Stirzaker C; Mahmud N; Mein CA; Clark SJ; Robinson MD, 2013, BayMeth: Improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach, http://dx.doi.org/10.48550/arxiv.1312.3115

Back to profile page